The interim results of Phase 3 clinical trials conducted by CanSinoBIO demonstrated that Convidecia has an efficacy of 95.47% at preventing severe disease 14 days after single-dose vaccination.
_256_384.jpg)
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants
Brii Bio announces amubarvimab/romlusevimab combination received approval from NMPA
Gland Pharma believes that they are amongst one of the first to file for this product and may be eligible for 180 days of generic drug exclusivity
Evusheld is a combination of two long-acting monoclonal antibodies and is the only antibody therapy authorised in the US to prevent Covid-19
Whipple procedure is a very complex operation, mainly performed to remove pancreatic cancer
Organised by the Indian Stroke Association, it has attracted over 800 doctors from India and overseas
It plans to add over 1000 employees over the next six months
Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected
A Care network is a digital health network that connects healthcare stakeholders to deliver streamlined care with the patient at the centre of the experience
Subscribe To Our Newsletter & Stay Updated
